2019, Number 4
<< Back Next >>
Rev Hematol Mex 2019; 20 (4)
Cutaneous T/natural killer cell, hidroa vacciniforme type lymphoma
Álvarez-Endara J, Sardinas-Castellón S, Vásquez-Rivera S
Language: Spanish
References: 17
Page: 278-282
PDF size: 293.81 Kb.
ABSTRACT
Hydroa vacciniform lymphoma is a rare, usually fatal, lymphoproliferative disease
caused by the Epstein-Barr virus that affects children in Asia, Mexico and South
America. Cutaneous manifestations mimic a benign photodermatosis. Cutaneous
lymphomas in children are rare. The data available are usually from adults, whose
incidence is 0.3/1,000,000 inhabitants. In them, the skin is the second location of
extranodal primary lymphomas. We report the case of a male patient of 13 years
with generalized cutaneous involvement, triggered by sunlight. A skin biopsy was
performed, which led to the diagnosis of cutaneous hydrophilic lymphoma. He received
treatment with 2 cycles of CHOP (cyclophosphamide, vincristine, doxorubicin
and prednisone) and later with COMP (cyclophosphamide, vincristine, methotrexate
and prednisone) obtaining a partial remission of the skin lesions. The report of this
case is considered significant since there are few cases reported in the international
literature and in Bolivia we do not have a real case history of the presentation of
this clinical picture.
REFERENCES
Miranda MF. Hydroa vacciniforme - Linfoma de células T similares: otro caso brasileño. Am J Dermaphatol 2018;40:P 201-204.
Maldonado García CA, Beirana Palencia A. Hidroa vacciniforme, revisión del tema Rev. Cent Dermatol Pascua 2006;15:198-20.
Larangeira de Almeida H Jr, et al. Extensive hydroa vacciniforme. An Bras Dermatol 2013;88(4):620-2. doi: 10.1590/ abd1806-4841.20131867.
Gallegos Riofrío X y col. Linfoma cutáneo de células T tipo hidroa vacciniforme. Reporte de caso. Med Cutan Iber Lat Am 2018;46(3):201-208.
Rosen S, Querfeld C. Primary cutaneous T-cell lymphomas. Hematology Am Soc Hematol Educ Program 2006:323-30, 513. DOI: 10.1182/asheducation-2006.1.323.
Quintanilla-Martinez L. Hydroa vacciniforme-like lymphoma: a chronic EBV+ lymphoproliferative disorder with risk to develop a systemic lymphoma. Blood 2013;122:3101- 3110. doi: 10.1182/blood-2013-05-502203.
Quero-Hernández A, Sánchez-Navarro LM, Socorro-López Z, Carrasco- Daza D. Linfoma cutáneo angiocéntrico de células T que semeja hidroa vacciniforme. Bol Med Hosp Infant Mex 2005;62:50-55.
Iwatsuki K, Satoh M, Yamamoto T, et al. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders. Arch Dermatol 2006;142:587-95. DOI: 10.1001/archderm.142.5.587.
Wada T, Toga A, Sakakibara Y, et al. Clonal expansion of Epstein-Barr virus (EBV)-infected γδ T cells in patients with chronic active EBV disease and hydroa vacciniforme-like eruptions. Int J Hematol 2012;96(4):443-449. doi: 10.1007/ s12185-012-1156-0.
Duvic M, Edelson R. Cutaneous T-cell lymphoma. J Am Acad Dermatol 2004;51(1):43-45.
Feng S, Jin P, Zeng X. Hydroa vacciniforme-like primary cutaneous CD8-positive T-cell lymphoma. Eur J Dermatol 2008;18:364-365. doi: 10.1684/ejd.2008.0428.
Duque Giraldo VE; Velásquez Lopera MM. Medellín Oct./ Dec. Iatreia 2011;24(4).
Huh SY, Choi M, Cho KH. A Case of Epstein-Barr Virus-associated hydroa vacciniforme. Ann Dermatol 2009;21:209-12. doi: 10.5021/ad.2009.21.2.209.
Lysell J, Wiegleb Edström D, Linde A, Carlsson G, Malmros- Svennilson J, Westermark A, et al. Antiviral therapy in children with hydroa vacciniforme. Acta Derm Venereol 2009;89:393-7. doi: 10.2340/00015555-0670.
Young Jae K, et al. Two cases of hydroa vacciniforme‐like lymphoproliferative disease controlled by anti‐inflammatory agents. Photodermatology, Photoinmunology and Photomedicine 2017;33:287-290. DOI: 10.1111/ phpp.12318.
Magaña M, Massone C, Magaña P, Cerroni L. Clinicopathologic features of hydroa vacciniforme-like lymphoma: A series of 9 patients. Am J Dermatopathol 2016 Jan;38(1):20-5. doi: 10.1097/DAD.0000000000000385.
Sangwan A, Aggarwal K, Kaur S, Jain VK. Adult-onset hydroa vacciniforme: A rare occurrence or a lymphoma premonition? Indian Dermatol Online J 2017;8:490-1. doi: 10.4103/ idoj.IDOJ_286_16.